Font Size: a A A

Lesions Of The Esophagogastric Junction:Expressions And Effects Of APC And β-CATENIN

Posted on:2013-03-08Degree:MasterType:Thesis
Country:ChinaCandidate:S LiFull Text:PDF
GTID:2234330374983549Subject:Digestive medicine
Abstract/Summary:
Background:In recent years, the prevalence of distal gastric cancer in Western developed countries continue to decline, while the incidence of adenocarcinoma of the esophagogastric junction (AEG) has increased annually. The long-term survival of AEG is poor and depends on the possibility of performing a complete surgical excision and the absence of lymph node involvement. At presence, there is few studies on the molecular mechanism of its pathogenesis, and most scholars believe that intestinal metaplasia(M) is one of the risk factors of AEG. The intestinal epithelium may have two sources:intestinal metaplasia at Barrett’s esophagus(BEM) and at cardia(CM), whether they belong to the same disease and have the same risk for development of adenocarcinoma, there is still a lot of controversy.Purpose:To study the expressions of APC and β-Catenin in lesions of esophagogastric junction, and to investigate the correlation of the intestinal metaplasia between at Barrett’s esophagus(BE) and at cardia, and the evolution of adenocarcinoma of the esophagogastric junction.Methods: The immunochemistry method was used to detect APC and β-Catenin proteins expressions in33BEM specimens,36CM specimens, and42AEG specimens (Poorly differentiated27; Moderated differentiated8; Highly differentiated7).Results:APC located predominantly in the cytoplasm, and the expression level in the AEG group was weaker than the BEM and the CM group; β-Catenin in the BEM and the CM group, almost all expressed in the cell membrane, while in the AEG group, were expressed partly in the nucleus and cytoplasm. The positive rates of APC expression in the BEM, the CM and the AEG group, were87.9%,83.3%,57.1%, respectively; and β-Catenin were93.9%,88.9%,85.7%, respectively. The expression of APC was correlated well with the pathological grade of lesions (M--AEG Poorly differentiated-Moderated differentiated-Highly differentiated), while β-Catenin was not correlated completely.Conclusions:1. APC protein may be involved in the development of the intestinal metaplasia-adenocarcinoma in the esophagogastric junction, and its expression levels decrease with increasing degree of malignancy.2. The expressions of β-Catenin in the BEM group, CM group and AEG group are different, and its ectopic expression may play a role in the development of AEG.3. The positive rates of APC and β-catenin in the BEM group and CM group are of no significant difference, and there is a similar expression characteristics of APC and β-catenin between the two intestinal metaplasia correlating with the AEG, the BEM and CM may be the same kind of lesion.4. BEM and CM are risk factors of the AEG.
Keywords/Search Tags:Adenocarcinoma of the esophagogastric junction, Barrett’s esophagus, APC, β-Catenin
Related items
The Expression Of TAZ In Adenocarcinoma Of The Esophagogastric Junction And Its Clinical Significance
Application And Significance Of HTERC Gene Amplification And Series Antibody Expression In Pathologic Diagnosis Of Barrett’s Esophagus
Characteristics And Clinical Significance Of Lymph Node Metastasis In Adenocarcinoma Of The Esophagogastric Junction And The Reserch Of Molecular Mechanism
Comparison Postoperative Gastric Emptying For Advanced Adenocarcinoma Of Esophagogastric Junction (Siewert Type Ⅱ) With Anastomosis Of Esophagus And Narrow Gastric Tube With Distal Half Stomach
Risk Factors Of Peirneural Invasion In Patients With Advanced Adenocarcinoma Of Esophagogastric Junction
Comparison Of Prognostic Value Between Gastric Cancer And Esophageal Adenocarcinoma Staging System In Evaluation Of The Patients With Locally Advanced Siewert Type Ⅱ Adenocarcinoma Of Esophagogastric Junction
The Study Of The Therapeutic Effects Of Two Surgical Approaches For Siewert Type â…¡, â…¢ Adenocarcinoma Of Esophagogastric Junction
Perioperative Period And Long-term Survival Of Adenocarcinoma Of Esophagogastric Junction Treated By Different Surgical Approaches Clinical Study
The Recent Efficacy Of Different Surgical Approaches For Treating Siewert Ⅱ Adenocarcinoma Of The Esophagogastric Junction
10 The Value Of Predicting Human Epidermal Growth Factor Receptor 2 Status In Adenocarcinoma Of The Esophagogastric Junction In Different Models Of CT-based Radiomics